IASO PHARMA
IASO Pharma Inc. is a development stage company focusing on development of therapeutics for the treatment and prevention of infectious diseases. It offers antibiotics. The company was formerly known as Pacific Beach Biosciences, Inc. and changed its name in April, 2010. It was founded in 2006 and is based in San Diego, California.
IASO PHARMA
Industry:
Biotechnology Pharmaceutical Therapeutics
Founded:
2006-01-01
Address:
San Diego, California, United States
Country:
United States
Total Employee:
11+
Status:
Active
Total Funding:
3.34 M USD
Current Employees Featured
More informations about "IASO Pharma"
IASO Pharma - Crunchbase Company Profile & Funding
IASO Pharma Inc. is a development stage company focusing on development of therapeutics for the treatment and prevention of infectious diseases. It offers antibiotics. The company was formerly known as Pacific Beach Biosciences, …See details»
Organization | IASO Pharma Inc.
IASO Pharma Inc. Report issue. For profit Phase 1 Phase 2. Founded: San Diego CA United States (2006) Status: Acquired by Eli Lilly (1990 ...See details»
Iaso Therapeutics Announces First Close in $1.25M Equity Series …
Jan 25, 2023 Michigan State University biotechnology startup accelerates commercialization of novel protein carriers for vaccine development. January 25, 2023 East Lansing, MI – Iaso …See details»
IASO Biotherapeutics’ Equecabtagene Autoleucel, the World’s First …
May 20, 2022 Relying on its management team with strong execution, rich product pipeline, unique innovative R&D and business model, IASO Bio is determined to grow into an influential …See details»
Umoja Biopharma and IASO Biotherapeutics Announce Research ...
SEATTLE, SAN JOSE, Calif., SHANGHAI, NANJING, China, November 21, 2022 – Umoja Biopharma, Inc., an immuno-oncology company pioneering off-the-shelf, integrated …See details»
IASO BioTherapeutics（驯鹿生物） - LinkedIn
Pharmaceutical Manufacturing Boulder, Colorado Remix Therapeutics Biotechnology Research ... IASO BioTherapeutics（驯鹿生物） | 1,570 followers on LinkedIn. Transforming innovation into life ...See details»
IASO Pharma - Contacts, Employees, Board Members, Advisors
IASO Pharma is a development stage company developing therapeutics for the treatment and prevention of infectious diseases.See details»
IASO Pharma - Funding, Financials, Valuation & Investors
IASO Pharma is a development stage company developing therapeutics for the treatment and prevention of infectious diseases. Search Crunchbase. Start Free Trial . Chrome Extension. …See details»
Cabaletta Bio and IASO Biotherapeutics Announce Exclusive …
Oct 11, 2022 PHILADELPHIA, Pennsylvania and SAN JOSE, California, NANJING and SHANGHAI, China — October 11, 2022 — IASO Biotherapeutics ("IASO Bio"), a clinical-stage …See details»
IASO Biotherapeutics and Innovent Biologics to Present New …
Nov 10, 2021 SAN JOSE, CALIF., NANJING, CHINA and SHANGHAI, Nov 10, 2021 – IASO Biotherapeutics (“IASO Bio”), a clinical-stage biopharmaceutical company focused on …See details»
IASO Biotherapeutics Secures $108 Million Series C Funding to …
September 16, 2021, PLEASANTON, Calif. & NANJING, SHANGHAI, China – IASO Biotherapeutics (IASO Bio), a clinical-stage biopharmaceutical company focusing on …See details»
IASO Bio Announces NMPA's IND Approval for Equecabtagene …
Mar 29, 2024 SHANGHAI, NANJING, CHINA, AND SAN JOSE, Calif., March 28, 2024 - IASO Bio, a biopharmaceutical company engaged in discovering, developing, manufacturing and …See details»
IASO BIO Announces New Development Partnership with Umoja …
IASO Bio is a biopharmaceutical company engaged in the discovery and development of novel cell therapies and biologics for oncology and autoimmune diseases. IASO Bio possesses …See details»
IASO Biotherapeutics - Crunchbase Company Profile & Funding
IASO Biotherapeutics may be growing as it has recently achieved a significant regulatory milestone and secured substantial venture funding. The company, in collaboration with …See details»
IASO Bio Receives U.S. FDA Approval of Investigational New Drug ...
Aug 12, 2024 /PRNewswire/ -- IASO Biotherapeutics ("IASO Bio"), ... Pharmaceuticals. News Releases in Similar Topics Contact PR Newswire. Call PR Newswire at 888-776-0942 from 8 …See details»
IASO Bio Raises Nearly $75 Million in Series C1 Funding - PR …
Jan 18, 2023 NANJING and SHANGHAI, China and SAN JOSE, Calif., Jan. 17, 2023 /PRNewswire/ -- IASO Biotherapeutics (IASO Bio), a clinical-stage biopharmaceutical …See details»
IASO Biotherapeutics’ World’s First Fully Human CD19/CD22 Dual …
Aug 2, 2021 PLEASONTON, CALIF., NANJING, and SHANGHAI, July 29, 2021 - IASO Biotherapeutics (IASO Bio), a clinical-stage biopharmaceutical company advancing the …See details»
IASO Bio and Innovent Enhance Strategic Collaboration in Cell …
Jul 5, 2024 According to the agreement, IASO Bio will purchase Innovent’s relevant rights of FUCASO ® under the original "BCMA CAR-T Cell Therapy Cooperation Agreement" at the …See details»
IASO Bio Receives U.S. FDA Approval of Investigational New Drug ...
Jul 24, 2024 IASO Bio is a biopharmaceutical company engaged in the discovery and development of novel cell therapies and biologics for oncology and autoimmune diseases. …See details»